
Product Journeys: BioNTech (Covid-19 Vaccine)
Rocketship.fm
00:00
M R an a Flue Vaccines
This journey started in january this year and was devoted to the development of an e, well tolerated and effective covet nineteen vaxcine following the highest scientific and ethical standards. The technology behind the spek seen, the messenger ana technology and the rexine candidates have beendevelopedin germany. Biinte received a hundred and twenty million in up front equity and near term research payments for m r n a base flue vaccines.
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.